Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors - Kim, Seung Tae; Choi, Yoon Ji; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Shin, Sang Won; Kim, Jun Suk; Kim, Yeul Hong (Chemotherapy (Basel), 2011)
Keywords: Adenocarcinoma - drug therapy; Adenocarcinoma - genetics; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Agents - therapeutic use; Asian Continental Ancestry Group; Asian people; Chemotherapy; Clinical Study; Codon; ErbB Receptors - antagonists & inhibitors; ErbB Receptors - genetics; Exons; Female; Genes, erbB-1; Humans; Kinases; Lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Male; Middle Aged; Mutation; Pharmacology; Protein Kinase Inhibitors - therapeutic use; Smoking; Epidermal growth factor receptor mutation; Tyrosine kinase inhibitors; Lung adenocarcinoma